Xatmep Solution
Product Images NDC 52652-2001

2 FDA label images from Azurity Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Xatmep (NDC 52652-2001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
Chemical structure of methotrexate showing its molecular formula C20H22N8O5 and molecular weight 454.45.*
FDA Label Image

Principal Display Panel (Bottle Label)

Principal Display Panel (Bottle Label)
Label for Xatmep (methotrexate) oral solution 2.5 mg/mL by Azurity Pharmaceuticals. The 120 mL bottle label includes dosage strength, route (oral), cytotoxic agent caution, storage instructions, and NDC 52652-2001-1. It is marked for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.